MONTVALE, N.J., June 30, 2008 (PRIME NEWSWIRE) -- Ivivi Technologies, Inc. (Nasdaq:IVVI), a leader in non-invasive, electroceutical(r) therapy systems designed to target and enhance the body’s anti-inflammatory response, today announced financial results for its fiscal fourth quarter and year ended March 31, 2008.
